chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have had like though out like my body; I am like tingling, prickliness with my leg was falling asleep; my foot is falling asleep; it comes and goes and it just kind of leave throughout; I have had like though out like my body; I am like tingling, prickliness with my leg was falling asleep; my foot is falling asleep; it comes and goes and it just kind of leave throughout; Feels like little pinching needles issue in my lips as well; I almost feel like you know like a body part is falling asleep and all of a sudden it starts to come back; Mild type numb feeling; Feels like little pinching needles issue in my lips as well; I almost feel like you know like a body part is falling asleep and all of a sudden it starts to come back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization. The following information was reported: PARAESTHESIA (non-serious), FEELING ABNORMAL (non-serious) all with onset 2021, outcome "unknown" and all described as "I have had like though out like my body; I am like tingling, prickliness with my leg was falling asleep; my foot is falling asleep; it comes and goes and it just kind of leave throughout"; PARAESTHESIA ORAL (non-serious), DISCOMFORT (non-serious) all with onset 2021, outcome "unknown" and all described as "Feels like little pinching needles issue in my lips as well; I almost feel like you know like a body part is falling asleep and all of a sudden it starts to come back"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "Mild type numb feeling".  Additional Information: Patient stated just received second dose of Pfizer an hour and about 20 minutes ago and since then patient have had like a though out like my body, patient like tingling, prickliness with leg was falling asleep and foot is falling asleep. But it comes and goes and it just kind of leave throughout. Kind of sometimes feels like little pinching needles issue in lips as well. Patient almost feel like a body part is falling asleep and then all of a sudden it starts to come back and kind of have like it. Mild type numb feeling but then it comes back after it, like coming and falling asleep. So feeling that all throughout but it just leaves the way out different parts of the body.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received vaccine at urgent care.  There was no pain at injection site.  I recall that it was in the left arm, however, consent form states right arm.  Symptoms occurred about a week later.  At first I had neck spasms and thought it might be the way I was sleeping.  I took Ibuprofen at night for over a week.  I noted pain in upper arm and in forearm.  I am not on any meds and I continued taking Ibuprofen and alternating nights with acetaminophen.  Approximately 2 months later I still have some upper arm pain.  I contacted NP on 12/23/19 just to inquire as to whether other employees had symptoms.  She stated that the have 3-5/year out of 3000 employees who have indicated similar discomfort. I elected not to go to clinic as it appeared to be improving.  Treatment that might have been used would be steroids that would have affected my blood glucose as I am pre diabetic and maintain my fasting blood glucose at ~115 mg/dl for past 15 years.  I am going to consider other locations for receiving vaccine in future as this has been uncomfortable and I question doing physical activities that require lifting and/or upper body strength.
Left arm very painful.  Limited range of motion, hard time dressing.  I had bouts of this shortly after the vaccine, but now, Dec. 29, 2021 constant pain I'd rate on the pain scale as a 4.  I'm aware of it always and it limits some of my activities.
NONE: GIVED EXPIRED COVID -19 VACCINE ON 10/25/2022: Given 01/12/2023
Tested positive for Covid-19 more than 14 days after completing Pfizer Covid-19 vaccination series
The day after the shot, June 9th, he had pain in his armpit and a bit on his left side.  Later in the day he felt a lump in his armpit (I am assuming lymph node).  It hurt to touch the lump and hurt any time he moved his arm.  Pain continued today, June 10th, and the lump under his arm is quite big at around 1.5 inches.  It is squishy to touch.  Painful to touch or move arm all day today as well.  No other symptoms (no fever, chills, etc).
This spontaneous report as received from a Nurse practitioner refers to an unknown number of patients of unknown ages and genders. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with improperly stored doses of VARIVAX (lot number M003440 expiration date 20-JAN-2018). Dose, route and frequency were not provided. No other suspect or concomitant therapy was reported. The doses were stored at 15.6 F for 1800 hours. The reporter stated that their office was not aware of any adverse effects from these administrations. This is one of two reports received from the same reporter (1607USA001830). Additional information has been requested.
This spontaneous report as received from an other refers to patients of unknown age. On an unknown date the patients were vaccinated with an improperly stored dose of M-M-R II for prophylaxis. Concomitant therapies included sterile diluent (STERILE DILUENT). On an unknown date the patients experienced no adverse event. The outcome of incorrect product storage and no adverse event was unknown. The reporter considered incorrect product storage and no adverse event to be not related to M-M-R II.; Sender's Comments: US-009507513-1707USA010451: US-009507513-1707USA010526: US-009507513-1707USA010527: US-009507513-1707USA010528: US-009507513-1707USA010530: US-009507513-1707USA010531: US-009507513-1707USA010532:
Dizziness and weakness resulting in a fall the evening of the vaccination.  Paramedics were called, but patient was not transported to the hospital.  Vital signs were okay.  Extreme fatigue and continued dizziness for several days.  Increased brain fog and confusion.
Rash on the left side of the chest and the left arm above where the the vaccine was administered. Headache and soreness on the left arm. Motrin was taken for headaches.
2 hours after vaccination head to toe rash occurred. next day  SOB and cough started. lasred about  i week.
some severe nausea to the point started on the 11Jan2021 that was very hard for her to talk to people; Soreness in my arm; Headache; This is a spontaneous report from a contactable consumer reported for self. This 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 06Jan2021 at single dose for covid-19 immunisation. Medical history and concomitant medications were none. And right after the vaccine the patient was okay. Into the next day (07Jan2021) the patient had soreness in her arm, and headache which was known as a common side effect of the vaccination. But as of Monday, had been experiencing some severe nausea to the point started on the 11Jan2021 that was very hard for her to talk to people. Because she was almost gag in. Every time she talked she felt like she was going to throw up just if she was upright she felt like she had to throw up. So, she reached out to her employee health services and they asked her to reach out to you guys. She just wanted to add that she didn't experience this portion right away, it took some days for her to feel this. No treatments received for the event nausea. Outcome of the event nausea was not recovered. Outcome of other events was unknown.  information on the lot/batch number has been requested.
This spontaneous report as received from a physician refers to a female patient of unknown age with allergy to tartrazine.  On 13-JUL-2015, the patient was vaccinated with a first dose of ZOSTAVAX (dose, route of administration, lot # and expiry date were not reported). During the same office visit, the patient was scheduled for early cancer screening. On an unspecified date in 2015 (reported as "within the last week"), the patient received inadvertently the second dose of ZOSTAVAX (dose, route of administration, lot # and expiry date were not reported). On 12-AUG-2015, the patient had a colonoscopy and a biopsy showed adenocarcinoma. The physician reported, that the patient had early colon cancer and would have staging surgery, in September 2015 (reported as "in the next two weeks"). The reporter also stated, that the patient had "no major side effects" (exact onset date unspecified, in 2015). The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not provided. Upon internal review the event of adenocarcinoma was considered to be medically significant. Additional information has been requested.
Patient presented to primary care office on Oct. 23, 2017 for 2 month well child check and received routine vaccines PEDIARIX, ACTHIB, Pneumococcal and ROTATEQ. Manager received a phone call for County Department of Health that the child passed away on Nov. 4, 2017.
This spontaneous report was received from a registered nurse via a company representative concerning a female patient of unknown age. On an unknown date in 2007, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date and dose unspecified), subcutaneously. No concomitant therapy was reported. Approximately on an unknown date in October 2013 (reproted as within the last month), the patient developed shingles on their face. The patient sought medical attention (doctor's visit). It was unspecified if any treatment was provided of if any lab tests were performed. The outcome of shingles on their face was unknown. The relatedness for the event was unknown for ZOSTAVAX. Additional information has been requested.
She woke up Friday 26Feb2021 with pain under the right breast and right arm that went down to the waist; This is a spontaneous report from a contactable consumer. A 84-year-old female patient (non-pregnant at the time of vaccination) received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: Unknown) (age at vaccination: 84 years) via an unspecified route of administration on right arm on 25Feb2021 03:45 PM as single dose for covid-19 immunization. The patient medical history included allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient Concomitant medications were not reported. Historical vaccine included patient received first dose of bnt162b2 (BNT162B2, Batch/Lot Number: unknown), via unspecified route of administration on left arm on 04Feb2021 at 04:30 PM. The patient had not received any other vaccine in 4 weeks. On Friday, 26Feb2021 at 08:00 AM, patient woke up with pain under the right breast and right arm that went down to the waist. The patient did not receive any treatment for the events. The Outcome of the event was recovering  No follow up attempts are possible; information on Lot/batch number cannot be obtained.
Headache; Loss of Appetite; Fatigue; Muscle Aches; Injection Site Hardness; pain everywhere; extreme Pain in Legs; trouble sleeping at night; This case was reported by a consumer via call center representative and described the occurrence of headache in a 20-year-old female patient who received Men B NVS (Meningococcal B vaccine) (batch number not known, expiry date unknown) for prophylaxis.   On 18th December 2019, the patient received Meningococcal B vaccine (intramuscular). On 18th December 2019, 10 hrs after receiving Meningococcal B vaccine, the patient experienced headache, appetite lost, fatigue, muscle pain, injection site induration, general body pain, leg pain and difficulty sleeping. On an unknown date, the outcome of the headache, appetite lost and fatigue were recovering/resolving and the outcome of the muscle pain, injection site induration, general body pain and leg pain were resolved with sequelae and the outcome of the difficulty sleeping was unknown.   It was unknown if the reporter considered the headache, appetite lost, fatigue, muscle pain, injection site induration, general body pain, leg pain and difficulty sleeping to be related to Meningococcal B vaccine.  Additional details were provided as follows: The case was reported by patient's mother. The age at vaccination was not reported. The reporter stated that the patient received meningitis B vaccine (unknown manufacturer).  The patient had a headache, fatigue, muscle aches, injection site hardness, loss of appetite, pain everywhere, extreme pain in legs, and trouble sleeping at night due to pain.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient was between the age of 10 and 18 years. Pertinent medical history and drug reactions or allergies were not specified. On 01-APR-2014, the patient was vaccinated with a dose of GARDASIL (dose in series unspecified) 0.5 mL, once, intramuscularly, lot number J006850, expiry date 31-MAR-2016 or J011272, expiry date 21-APR-2016, that was exposed to 30 Fahrenheit (F) for 10 minutes on 06-MAR-2014. No adverse effects were reported. This is one of several reports received from the same reporter (linked to MARRS # 1405USA008203, 1405USA0082972, 1405USA008973, 1405USA008974, 1405USA008975, 1405USA008977, 1405USA008978, 1405USA008979, 1405USA008980, 1405USA008981, 1405USA008982). Additional information has been requested.
multiple sclerosis; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 27Mar2021 10:00 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation.  Medical history included low iron and low vitamin D. Patient was not pregnant. There were no concomitant medication within 2 weeks and no other vaccine were administered 4 weeks prior to covid vaccine. Patient developed multiple sclerosis on 19Apr2021 (as reported), 19 days after the first injection. Patient had historically have low iron and low vitamin D and didn't realize that correlated to risk factors for multiple sclerosis. Patient stated who have those risk factors that they should not get the vaccine since it can create an immune response bringing out MS. The adverse event resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage. Treatment received for the adverse event included steroids and MS management medications. Outcome of the event was not recovered. Patient did not have covid prior to vaccination and had not been tested post-vaccination. The reporter considered the event serious (disabling).  Information on the lot/batch number has been requested.
pt recv vax & few hrs later inj site LAT became red, swollen & black & blue; redness was size of egg & black & blue area; size of half dollar; says could feel knot that was as big as the bruised area; pt fussy w/moving leg but no other sx
Within 5 mins of receiving vaccine, pt became pale, forehead was clammy.Pt stated she did not feel well.PHN had pt lower head.  BP 110/80, P 60, Mother mentioned pt had eated poorly at school. Within 2 minutes pt felt better but still pale.
Following the vaccination she developed a small fever just below 100 degrees.  Her legs were extremely sore to the degree that she did not do any walking for about 6 hrs after the soreness began 1 1/2 hrs after the vaccination.  This was not concerning to us because we expected some local inflamation.  About 28 hours after her vaccination she was inconsolable and was screaming "NO" repeatiably.  She was tired and we thought that this was extremely unusual behavior for her so we tried to lay her down.  She screamed herself to sleep.  She awoke after 1hr screaming and then fell back asleep after about 10 minutes.  She then slept about 1-2 more hours more and woke up completely inconsolable and unreachable with communication.  This began concerning us because this was extremely unusual behavior for her.  No communication, food, treats, or anything we could think of would bring her out of this state.  When picked up she kicked and screamed even more.  After about an hour of this she appeared worn out and finally stropped screaming.  She laid on her moms shoulders again and started to calm down.  Her behavior and communication were extremely poor the rest of the night until we laid her back down for bed.  The next morning (today)she appeared much better and was communicating and responding much better.  She still does not seem to be quite herself.
Sore arm at injection site, followed by a low grade headache.  Arm became swollen and hard and very sore; muscle pain in arm. Headache more intense, felt 'crappy' all over. Went to bed and within a couple of hours had chills to the point of shivering and used a heating pad to warm up. Stayed in bed all the next day on Wednesday (10/20) with muscle aches, fatigue, and total loss of appetite - ate one cup of clear chicken broth. Felt dizzy and nauseous, especially when out of bed. Headaches continued throughout the day.  Began to feel much better 24 hours after onset of side effects. Woke up the next day (Oct 21 - today) feeling just fine - like normal. Wow!
Patient started to  feel dizzy , skin color getting  pale , cold hands , sweat , and was about  to faint 5 minutes after administering the vaccine .  pharmacist on duty grabbed the Epipen  and blood pressure machine . patient blood pressure  was 65/40 ,  patient started to  feel better  for couple minutes then he start to feel dizzy and to get same symptoms again    ,  at this moment pharmacist injected the patient with Epipen as he stated  he iwas fainting .patient denied to have any allergies , fear for needles or any health conditions .  pharmacist kept watching and monitoring the patient till his blood pressure came back to 118/69. patient family came to pick him up .
Patient received third dose of pfizer vaccine to right deltoid at 11:51am inside POD. Patient presented to observation at approximately 12:00pm 12:15 Patient reported "tingling of back of tongue" and "strange vision" Denied shortness of breath, chest pain, lightheadedness and dizziness. Patient states no reaction to previous two doses. Patient has had previous anaphylactic reaction to unknown food source was given epi pen in case of future reaction, states she does not know how to use it. Notified NP for further assessment. During NP assessment patient stated she had been fasting and had not eaten today. Patient noted to be able to tolerate fluids at time of arrival. 12:25 Vital signs 110/70, Pulse-59bpm and SpO2 99%. At this time patient complained of new numbness at center of lip. Patient denied swelling/itching/tingling of the throat, shortness of breath or chest pain. 12:30pm Patients ability to swallow further assessed by N.P, patient able to Swallow crackers without issue. Patient to be reassessed every 15 minutes per NP. 12:45 Continued to monitor patient, SpO2 99% pulse-58bpm. Patient continued to eat crackers without issue. Per patient symptoms unchanged. 13:00 Patient reports some improvement in ?strange sensation? after drinking fluids and eating crackers, SpO2 99%, pulse-59bpm. NP consulted with Medical director Dr. , advised that after third dose it is unlikely that it is an allergic reaction to vaccine. 13:15 Patient reported no further worsening of symptoms, SpO2 98% pulse- 64bpm. NP relayed advisement from Dr.  to patient, no further questions at this time. Advised patient to review instructions for Epi pen, advised to seek medical attention if symptoms worsen. Vital signs stable, symptoms improved. Patient stable to leave. Patient declined higher level of care, aware of emergency precautions.
Fever two days after.  Melt downs.  Acting as if in a fog.  Blinky eyes in strange manner.  Running in circles.  Stopped babbling and saying words she did have.  Lack of eye contact.  Lack of any kind of connection to parents and others.
This is 70-year-old female with extensive cardiac history CHF cardiomyopathy, supranuclear palsy, breast cancer, hypertension came to the ED today with complaints of shortness of breath. EMS was called to the home to bring the patient into the ER as she was feeling very weak and unable to catch her breath. The patient is positive for covid 19 at home and confirmed positive here.
No adverse event; A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022) and NO ADVERSE EVENT (No adverse event) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M21A, 025L20A, 030L20A and 069H21A) for COVID-19 prophylaxis.     Acute illness at the time of vaccination, chronic illness or if patient has ever been diagnosed with COVID-19 was unknown.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 dosage form. On 26-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines/ expiration date 13Jul2022 Date(s) of administration of vaccine were -26Jul2022).    No concomitant medications was reported. No treatment medications was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704260 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2023: Significant follow up received. Route of administration and dose detail for 4th dose and narrative was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704260:(Master case)
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 12-month-old female patient who experienced possible seizure, cramps and pain. At 12 months of age, the patient received a dose on 01-Jul-2010 in the morning (time unspecified), along with a dose of Varicella Virus Vaccine, Live (manufacturer unknown) and a dose of MMR II (Merck Sharp & Dome). On 01-Jul-2010 in the afternoon (time unspecified), the patient experienced possible seizure, cramps and pain. The patient was taken to the emergency room and subsequently hospitalized. Treatment was not reported. The patient's outcome was unknown. No additional information was available at the time of this report.